Skip to content
value.today

GRIP Molecular Technologies Inc.

Total raised
$12 M
1 round on record
Latest round
$12 M
Dec 2019
First round on record
Dec 2019
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GRIP Molecular Technologies Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2019$12 MNo. 1$10 to $50 million

GRIP Molecular Technologies Inc.: Raise no. 1, Dec 2019

Investors in this round

41 investors had bought by the notice of Oct 29, 2026: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $21 M offered; $9 M still to sell
Smallest investment taken
$10,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Batten · Executive Officer · Chief Scientific Officer
  • Edward Gillen · Executive Officer
  • Richard Minicus · Executive Officer · CFO
  • Edward Ludwig · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard G. Minicus, Cfo. Source: SEC Form D and 3 amendments, newest notice filed Oct 29, 2026. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • GRIP Molecular Technologies Inc. had no revenue when it filed its newest notice of a funding round (Oct 2026).

    SEC Form D (revenue range) · Oct 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Oct 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of GRIP Molecular Technologies Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 41 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GRIP Molecular Technologies Inc.
NameRoleNamed in
Bruce BattenExecutive officerMay 2025
Edward GillenExecutive officerMay 2025
Richard MinicusCFOMay 2025
Edward LudwigChairman of the BoardJul 2022
Rich MinicusExecutive officerJul 2022
Stasia OgdenGeneral CounselJul 2022
Bruce BattenDirectorMay 2025
Edward LudwigDirectorMay 2025
Edward GillenDirectorJul 2022